期刊文献+

不同标本前处理方法对血管紧张素测定结果的影响

Effect of different specimens pretreatment on determination of angiotensin
原文传递
导出
摘要 [目的]探讨不同的标本前处理方法对血管紧张素Ⅰ、Ⅱ(AⅠ、AⅡ)测定结果的影响。[方法]分别采用3种不同方法对40例病人的静脉血标本进行处理,分离血浆后用化学发光法检测AⅠ和AⅡ的水平。方法 1为按说明书用血常规真空管采血后立即加入酶抑制剂;方法 2为在血常规管中事先加好酶抑制剂再采血;方法 3为用血常规管采血后在冰箱放置1 h再加入酶抑制剂。[结果]方法 2检测出的AⅠ、AⅡ水平与方法 1的检测结果差异无统计学意义,方法 3检测的AⅠ、AⅡ水平明显低于方法 1。[结论]加酶抑制剂能抑制AⅠ、AⅡ、AⅢ等转换,先加入酶抑制剂和采血后再加入对检测结果均无明显影响,方法 2还可避免漏加抑制剂。 [ Objective ] To discuss the effect of different specimens pretreatments on determination of angiotensin I and II levels. [ Methods ] A total of 40 blood samples were collected and used by three different treatment methods ( method 1 : blood was drawn into EDTA - I(2 anticoagulated vacuum tube, then added with enzyme inhibitor immediately, method 2 : enzyme inhibitor was added to the EDTA - K2 antico- agulated vacuum tube first, then mixed with blood, method 3 : the enzyme inhibitor was added at one hour after blood drawn was placed in the refrigerator} , after separation of plasma, the levels of AI and All were detected by chemiluminescence. [ Results ] The results of AI and All by method 2 were not significantly different from those by the method 1. But the levels were significantly descended using method 3 as compared with method 1. [ Conclusion ] There were inhibitory effects of enzyme inhibitor on the conversion among AI ,All and Am. Adding enzyme inhibitor first makes no significant difference to detec- tion results from adding it after blood drawing and helps not to forget to add the inhibitor.
出处 《上海预防医学》 CAS 2013年第3期149-151,共3页 Shanghai Journal of Preventive Medicine
关键词 血管紧张素 检测 酶抑制剂 Angiotensin Determination Enzyme inhibitor
  • 相关文献

参考文献8

二级参考文献69

  • 1李燕平.重视分析前质量控制提高检验质量[J].中华检验医学杂志,2005,28(2):219-219. 被引量:84
  • 2刘彤,李广平.左房扩大与心房颤动关系的研究进展[J].临床心电学杂志,2005,14(3):212-214. 被引量:49
  • 3Le Heuzey JY, Marijon E, Chaehoua K, et al. Pathophysiology of atrial fibrillation: insights into the renin-angiotensin system [ J ]. Arch Cardiovasc Dis, 2008,101 (11-12) :787-791.
  • 4Schmitt J, Duray G, Gersh B J, et al. Atrial fibrillation in acute myocardial infarction: a systematic review of the incidence, clinical features and prognostic implications [ J ]. Eur Heart J, 2009,30 (9) :1038-1045.
  • 5Novo G, Guttilla D, Fazio G, et al. The role of the renin-angiotensin system in atrial fibrillation and the therapeutic effects of ACEIs and ARBs [J]. Br J Clin Pharmacol, 2008, 66(3) :345-351.
  • 6Dixen U, Ravn L, Soeby-Rasmussen C, et al. Raised plasma aldosterone and natriuretic peptides in atrial fibrillation [ J ]. Cardiology, 2007,108( 1 ) :35-39.
  • 7Darbar D, Motsinger A, Ritehie MD, et al. ACE I/D polymorphism modulates symptomatic response to antiarrhythmie drug therapy in patients with lone atrial fibrillation [ J ]. Heart Rhythm, 2007,4 (6) :743-749.
  • 8Ehrlich JR, Hohnloser SH, Nattel S, et al. Role of angiotensin system and effects of its inhibition in atrial fibrillation: clinical and experimental evidence [ J]. Eur Heart J, 2006,27(5) :512-518.
  • 9Healey JS, Baranchuk A, Crystal E, et al. Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers [ J ]. Am Coil Cardiol, 2005,45 ( 11 ) : 1832-1839.
  • 10Elliott M E,Catt K J.Drug therapy:angiotensin receptors and their antagonists[J].N Engl J Med,1996,334:1640.

共引文献98

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部